Malta - Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing
Since 2014, Malta Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing fell by 10.3% year on year. In 2019, the country was number 11 among other countries in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing with €4.3 Per Capita. Malta is overtaken by Czech Republic, which was number 10 at €7.5 Per Capita and is followed by Poland with €3.8 Per Capita. Belgium, Sweden and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Poland witnessed the best average annual growth at +17.5% per year, while Malta witnessed the worst performance at -10.3% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 4.30 |
| 2018 | 5.50 |
| 2017 | 5.10 |
| 2016 | 2.10 |
| 2015 | 5.80 |
Download all data from 2008 to 2019
How does Malta rank in Business Expenditure on R&D in Basic Pharmaceutical Products and Pharmaceutical Preparations Manufacturing?
| # | 14 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
829.00 | 2017 | NA | +2.1 % | View data | |
| 2 |
#2
Belgium
|
241.20 | 2019 | +3.0 % | +6.1 % | View data | |
| 10 |
#10
Czech Republic
|
7.50 | 2019 | -3.9 % | +6.8 % | View data | |
| 11 |
#11
Malta
|
4.30 | 2019 | -21.8 % | -10.3 % | View data | |
| 12 |
#12
Poland
|
3.80 | 2019 | +0.0 % | +17.4 % | View data | |